Erleada

Erleada® Apalutamide – Treatment for Prostate Cancer

Erleada® Apalutamide is an oral medication used to treat certain types of prostate cancer. It works by blocking the action of androgens (male hormones like testosterone), which can promote the growth of prostate cancer cells. By inhibiting androgen receptors, apalutamide helps slow the growth of cancer and reduce tumor spread.

Key Benefits:

• Hormone Therapy: Specifically targets the androgen receptor pathway, which is crucial in the development and progression of prostate cancer.
• Convenient Oral Treatment: Taken as a pill, making it easy to include in a daily treatment regimen.
• Effective in Advanced Stages: Proven to delay cancer progression in patients with non-metastatic castration-resistant prostate cancer (nmCRPC) and metastatic castration-sensitive prostate cancer (mCSPC).

Indications:

Apalutamide is used to treat:

• Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC): In men whose prostate cancer has not spread but continues to grow despite low testosterone levels.
• Metastatic Castration-Sensitive Prostate Cancer (mCSPC): For advanced prostate cancer that is still responsive to hormone therapy.

How It Works:

Apalutamide works by blocking the androgen receptor, preventing androgens (such as testosterone) from stimulating the growth of prostate cancer cells. This action helps slow the progression of the disease.

Important Considerations:

• Side Effects: Common side effects may include fatigue, rash, hot flashes, and an increased risk of falls or fractures.
• Consult Your Doctor to determine if apalutamide is the right treatment for your prostate cancer.